ArticleOsong public health and research perspectives2018

Treatment with Sofosbuvir and Daclatasvir (with or without Ribavirin) Improves Patient Reported Outcomes in Hepatitis C.

Lucas Pereira Jorge de Medeiros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.